FDA panel says Merck's sleep drug safe, effective at lower doseWASHINGTON (Reuters) - Merck & Co's experimental insomnia drug is safe and effective at the lower of two doses studied but not at the higher, a panel of medical experts said on Wednesday. The panel, which advises the U.S. Food and Drug Administration on ... Reuters, 10 hours ago |
792 images for us fda | ||||
Cartelisation of drugs to stop: FDAThe Maharashtra Food and Drug Administration (FDA) has decided to crack down on the cartelisation of the medicine and drug industry by asking companies to terminate their memorandums of understanding (MoU) in order to be able to manufacture drugs that are in ... Asian Age, 23 hours ago
FDA Says GMO Salmon Wont Harm Environment
Food Logistics, 1 day ago
FDA launches software to boost food contamination protection
Processing Magazine, 5 days ago
FDA Commissioner Hamburg to Discuss Collaboration at DIA's 2013 49th...
PRWeb, 6 days ago
More from: Med India, Med India...and 5 other sources
|
Daiichi may sue ex-Ranbaxy promoters for false infoExcerpts from Reporter's Diary on CNBC-TV18 Watch the full show ยป Stung by the US FDA USD 500 million penalty, Japan's Diiachi Sankyo is exploring legal remedies to sue ex-Ranbaxy promoters, reports CNBC-TV18. Diiachi says that certain former ... Moneycontrol.com, 17 hours ago
Daiichi exploring legal options against Ranbaxy's former promoters
Myiris, 1 hour ago
Ranbaxy may reduce global sales team
Rediff.com, 2 hours ago
Ranbaxy falls 7%, Daiichi may sue ex-promoters
Money Control, 3 hours ago
|
VARIAN MEDICAL SYSTEMS, INC.: Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System/PRNewswire/ -- Varian Medical Systems (NYSE:VAR) today announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Varian's diagnostic X-ray image processing workstation that combines radio frequency (RF) and digital ... 4 Traders, 20 hours ago
Covidien receives FDA clearance for Nellcor pulse oximetry portfolio for motion claims
Medical Devices Business Review, 1 day ago
Covidien Receives FDA 510(k) Clearance for Nellcor Pulse Oximetry Motion Claims
OSIX News, 2 days ago
Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System
TMC Net, 19 hours ago
|
Peregrine Pharmaceuticals wins FDA approval to commence Phase III registration trial of bavituximab in NSCLC patientsBiopharmaceutical company Peregrine Pharmaceuticals (NASDAQ:PPHM) said on Monday that it has formed a collaboration with the US Food and Drug Administration (FDA) to proceed with a Phase III registration trial design of its lead clinical ... Individual.com, 1 day ago
Pharmaxis, FDA agree on new trial for Bronchitol
Australian Financial Review, 2 days ago
Peregrine Pharma agrees with FDA on lung cancer trial design
Reuters UK, 2 days ago
Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in Second-Line Non-Small Cell Lung Cancer
Individual.com, 2 days ago
|
Biogen submits new MS drug for FDA approvalWESTON, Mass. -- Specialty drugmaker Biogen Idec said Tuesday it submitted a new injectable multiple sclerosis drug to the Food and Drug Administration for U.S. market approval. The drug, called Plegridy, is intended to treat patients with relapsing ... CNBC, 1 day ago
Biogen submits MS drug Plegridy to FDA
Pharma Times, 23 hours ago
FDA approves Biogen's oral MS drug, Tecfidera
Reuters, 1 month ago
More from: , Pharmacy Choice...and 2 other sources
|
Govt probed Ranbaxy Labs in 2008, but didnt ban itThe health ministry decided not to toe the US FDA's line because of three reasons cited in a report prepared by Drug Controller General of India's office. NEW DELHI: The Indian government had in late 2008 probed the US Food and Drug Administration's charges ... Economic Times, 1 day ago
After US, India to probe Ranbaxy's documents
Sify, 1 day ago
|
Hologic Gets FDA Approval For 3D Mammography Solution For BreastCancer ScreeningHologic Inc. (HOLX: Quote) announced that the U.S. Food and Drug Administration or FDA approved the use of Hologic's new C-View 2D imaging software. The company said C-View 2D images may now be used in place of the conventional 2D exposure ... RTTNews.com, 1 day ago
Hologic Receives FDA Approval for a New Low-dose 3D Mammography (Breast Tomosynthesis) Solution for Breast Cancer Screening
Sys-Con Belgium, 1 day ago
Hologic Inc Receives FDA Approval For New Low-dose 3D Mammography (Breast Tomosynthesis) Solution For Breast Cancer Screening
Reuters, 1 day ago
UPDATE: Hologic Receives FDA Approval for a New Low-dose 3D Mammography (Breast Tomosynthesis) Solution for Breast Cancer Screening
Pharmacy Choice, 1 day ago
|
BioElectronics Presents FDA Reclassification PanelFREDERICK, Md. "It's been 37 years since the FDA developed its medical device classification schema," Whelan said. "While the old classification of pulsed shortwave devices probably made sense in the 1970s, it is out of date in light of the dramatic ... PR Newswire, 1 day ago
|
Jiangsu Hengrui Gets FDA Drug CertificationJiangsu Hengrui Medicine Co., Ltd. (SHSE: 600276) revealed that a notice has been received from the Food and Drug Administration (FDA) saying that letrozole tablet produced by the company has gotten certification from the government agency and ... Individual.com, 2 days ago
FDA Approves Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP)?s Flagship Drug Plans ? ORMP, GILD, MNKD, CLSN, ONTY
Galaxy Stocks, 2 days ago
Hill-Rom Receives FDA 510k Clearance to Market MetaNeb 4.0 Airway Clearance System
Pharmacy Choice, 2 days ago
Oramed Pharmaceuticals Inc Receives FDA Clearance To Initiate Oral Insulin Trials In U.S.
Reuters UK, 3 days ago
More from: RxList, Reuters UK...and 53 other sources
|